Finance
Avant Immunotherapeutics receives grant to develop, manufacture Ty800 with VitriLife
Published in Vaccine Weekly, November 1st, 2006
The National Institute of Allergy and Infectious Disease (NIAID) of the National Institutes of Health (NIH) awarded this grant titled "Development and cGMP Manufacture of a Vitrified Typhoid Vaccine," which provides approximately $750,000 in funding to Avant.
"We are very pleased to receive this new SBIR grant and the NIAID's commitment to further development and cGMP manufacture of Ty800 with bulk drying processes...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-11-01)
More Articles from Vaccine Weekly
- Chickenpox Vaccine
Varicella vaccine was effective during outbreak in partially vaccinated population in Spain - Measles Vaccine
HLA-A2 epitopes for fusion and hemagglutinin proteins of measles virus protect against measles - Poliomyelitis Vaccine
Outbreak of poliomyelitis in China was caused by type 1 vaccine-derived poliovirus - Vaccine Safety
No causal association was found between encephalopathy and pertussis or measles vaccine - Alloimmunization
New findings reported from University libre of Bruxelles, Faculty of Medicine describe advances in alloimmunization - Alloimmunization
Studies from Emory University, Aflac Cancer Center and Blood Disorders Service update current data on alloimmunization - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
